Targeting NF?B mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Targeting NF?B mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol Ther. 2011 Apr 01; 11(7):678-89.